Resources

Connect with our mission to advance T1D care


T1D blood test icon

Screening involves a blood test covered by most patients’ insurance

A diabetes mellitus antibody panel examines blood for the presence of autoantibody proteins. These proteins indicate the autoimmune process in the pancreas has begun. This test is available through most diagnostic labs in the US.1,2


A community tied together

Support systems are available for families and patients with T1D. There is a network of advocates, healthcare providers, and educational groups ready to get involved today.

JDRF

JDRF, the leading global funder of T1D research, has launched a groundbreaking screening initiative for T1D: T1Detect.

VISIT NOW
TrialNet

TrialNet is an international network of leading academic institutions, endocrinologists, physicians, scientists and healthcare teams at the forefront of T1D research.

VISIT NOW
TCOYD

Taking Control of Your Diabetes (TCOYD) is an educational advocacy group for patients and the larger T1D community.

VISIT NOW
Beyond Type 1

Beyond Type 1 is a nonprofit focusing on advocacy, education, and the path to a cure for T1D.

VISIT NOW
Quest Diagnostics

Access more information about diabetes and which laboratory testing services are available through Quest Diagnostics.

VISIT NOW
LabCorp

Access the Diabetes Autoimmune Profile page for testing information and ordering instructions.

VISIT NOW

Downloadable resource

Overview of the Pathophysiology and Disease Progression of Type 1 Diabetes (T1D)

Downloadable presentation that provides an overview of the incidence, burden, autoimmune pathophysiology and disease progression of T1D, and illustrates the importance of proactive screening and preserving beta-cell function.

DOWNLOAD SLIDES

Brought to you by

Provention Bio Logo

1. Ziegler A-G, Kick K, Bonifacio E, et al; for Fr1da Study Group. Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany. JAMA. 2020;323(4):339-351.

2. Insel RA, Dunne JL, Ziegler A-G. General population screening for type 1 diabetes: has its time come? Curr Opin Endocrinol Diabetes Obes. 2015;22(4):270-276.